Skip navigation
Home
News
Products
about IR-World
Team
Customers
Partner
Contact
DE
EN
Communicators
are winners!
Text der Meldung
More News
15.06.2022
Sernova to Participate in the Truist Securities Cell Therapy Symposium, Symposia-cel in June
07.06.2022
Sernova Announces Positive Updated Phase 1/2 Clinical Data on Cell Pouch SystemTM at American Diabetes Association 82nd Scientific Sessions 2022
01.06.2022
Sernova Shares to Commence Trading on TSX on June 2, 2022
24.05.2022
Sernova Receives Conditional Approval to Up-list to the Toronto Stock Exchange
17.05.2022
Sernova and Evotec Enter into an Exclusive Global Strategic Partnership for iPSC-Based Beta Cell Replacement Therapy to Develop and Commercialize a ‘Functional Cure’ for Diabetes
09.05.2022
Sernova Announces Abstract on Phase 1/2 Trial with Cell Pouch Selected for Oral Podium Presentation at American Diabetes Association 82nd Scientific Sessions 2022
06.05.2022
Sernova to Participate in Multiple U.S. Healthcare Investor Conferences
02.05.2022
Sernova Announces 2022 Annual General Meeting Results
17.03.2022
Data Safety Monitoring Board Recommends Continuation of Phase 1/2 Clinical Trial with Sernova’s Cell Pouch System™ in Patients with Type-1 Diabetes
28.01.2022
Sernova Announces Peer Reviewed Publication Demonstrating Positive Preclinical Safety and Efficacy Indicators of Its Novel Cell Pouch System™ Therapeutic Approach for Treatment of Thyroid Disease
First
Previous
1
2
3
4
5
6
7
Next
Last